BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29403084)

  • 1. Precise pathologic diagnosis and individualized treatment improve the outcomes of invasive micropapillary carcinoma of the breast: a 12-year prospective clinical study.
    Li W; Han Y; Wang C; Guo X; Shen B; Liu F; Jiang C; Li Y; Yang Y; Lang R; Fan Y; Gu F; Niu Y; Zhang X; Zhang L; Wen HY; Fu L
    Mod Pathol; 2018 Jun; 31(6):956-964. PubMed ID: 29403084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in Prognostic Factors and Failure Patterns Between Invasive Micropapillary Carcinoma and Carcinoma With Micropapillary Component Versus Invasive Ductal Carcinoma of the Breast: Retrospective Multicenter Case-Control Study (KROG 13-06).
    Yu JI; Choi DH; Huh SJ; Cho EY; Kim K; Chie EK; Ha SW; Park IA; Ahn SJ; Lee JS; Shin KH; Kwon Y; Kim YB; Suh CO; Koo JS; Kim JH; Jeong BG; Kim IA; Lee JH; Park W
    Clin Breast Cancer; 2015 Oct; 15(5):353-61.e1-2. PubMed ID: 25776197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and prognosis study of breast carcinoma with micropapillary component].
    Chen L; Fan Y; Lang RG; Guo XJ; Sun YL; Fu L
    Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):228-32. PubMed ID: 17706112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Micropapillary Component Ratio on the Prognosis of Patients With Invasive Micropapillary Breast Carcinoma.
    Kaya C; Uçak R; Bozkurt E; Ömeroğlu S; Kartal K; Yazıcı P; İdiz UO; Mihmanlı M
    J Invest Surg; 2020 Jan; 33(1):31-39. PubMed ID: 29843540
    [No Abstract]   [Full Text] [Related]  

  • 5. Invasive micropapillary carcinoma of the breast had poor clinical characteristics but showed no difference in prognosis compared with invasive ductal carcinoma.
    Li G; Yang S; Yao J; Wang Z; Yao G; Liu M; Ye C
    World J Surg Oncol; 2016 Aug; 14(1):207. PubMed ID: 27492008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive micropapillary mucinous carcinoma of the breast is associated with poor prognosis.
    Liu F; Yang M; Li Z; Guo X; Lin Y; Lang R; Shen B; Pringle G; Zhang X; Fu L
    Breast Cancer Res Treat; 2015 Jun; 151(2):443-51. PubMed ID: 25953688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic study of invasive micropapillary carcinoma of the breast.
    Tang SL; Yang JQ; Du ZG; Tan QW; Zhou YT; Zhang D; Lv Q
    Oncotarget; 2017 Jun; 8(26):42455-42465. PubMed ID: 28418916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of invasive micropapillary and triple negative invasive ductal carcinoma of the breast.
    Chen HL; Ding A
    Breast; 2015 Dec; 24(6):723-31. PubMed ID: 26392199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive micropapillary carcinoma of the breast: a clinicopathologic study of 103 cases of an unusual and highly aggressive variant of breast carcinoma.
    Gokce H; Durak MG; Akin MM; Canda T; Balci P; Ellidokuz H; Demirkan B; Gorken IB; Sevinc AI; Kocdor MA; Saydam S; Harmancioglu O
    Breast J; 2013; 19(4):374-81. PubMed ID: 23714006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in prognostic factors and patterns of failure between invasive micropapillary carcinoma and invasive ductal carcinoma of the breast: matched case-control study.
    Yu JI; Choi DH; Park W; Huh SJ; Cho EY; Lim YH; Ahn JS; Yang JH; Nam SJ
    Breast; 2010 Jun; 19(3):231-7. PubMed ID: 20304650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast carcinoma with micropapillary features: clinicopathologic study and long-term follow-up of 100 cases.
    Chen L; Fan Y; Lang RG; Guo XJ; Sun YL; Cui LF; Liu FF; Wei J; Zhang XM; Fu L
    Int J Surg Pathol; 2008 Apr; 16(2):155-63. PubMed ID: 18417672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical relevance of micropapillary carcinoma of the breast: a case-control study.
    Vingiani A; Maisonneuve P; Dell'orto P; Farante G; Rotmensz N; Lissidini G; Del Castillo A; Renne G; Luini A; Colleoni M; Viale G; Pruneri G
    Histopathology; 2013 Aug; 63(2):217-24. PubMed ID: 23763700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer.
    Mercogliano MF; Inurrigarro G; De Martino M; Venturutti L; Rivas MA; Cordo-Russo R; Proietti CJ; Fernández EA; Frahm I; Barchuk S; Allemand DH; Figurelli S; Deza EG; Ares S; Gercovich FG; Cortese E; Amasino M; Guzmán P; Roa JC; Elizalde PV; Schillaci R
    BMC Cancer; 2017 Dec; 17(1):895. PubMed ID: 29281999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of molecular status on survival outcomes for invasive micropapillary carcinoma of the breast.
    Lewis GD; Xing Y; Haque W; Patel T; Schwartz MR; Chen AC; Farach A; Hatch SS; Butler EB; Chang JC; Teh BS
    Breast J; 2019 Nov; 25(6):1171-1176. PubMed ID: 31321854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysis.
    Chen H; Wu K; Wang M; Wang F; Zhang M; Zhang P
    Cancer Med; 2017 Dec; 6(12):2775-2786. PubMed ID: 29072365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive micropapillary carcinoma of the breast metastatic to the urinary bladder and endometrium: diagnostic pitfalls and review of the literature of tumors with micropapillary features.
    Ramalingam P; Middleton LP; Tamboli P; Troncoso P; Silva EG; Ayala AG
    Ann Diagn Pathol; 2003 Apr; 7(2):112-9. PubMed ID: 12715337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic features of invasive metaplastic and micropapillary breast carcinoma: comparison with invasive ductal carcinoma of breast.
    Hashmi AA; Aijaz S; Mahboob R; Khan SM; Irfan M; Iftikhar N; Nisar M; Siddiqui M; Edhi MM; Faridi N; Khan A
    BMC Res Notes; 2018 Jul; 11(1):531. PubMed ID: 30064485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic markers for invasive micropapillary carcinoma of the breast: a population-based analysis.
    Chen AC; Paulino AC; Schwartz MR; Rodriguez AA; Bass BL; Chang JC; Teh BS
    Clin Breast Cancer; 2013 Apr; 13(2):133-9. PubMed ID: 23246269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of ARID1A expression is associated with poor prognosis in invasive micropapillary carcinomas of the breast: A clinicopathologic and immunohistochemical study with long-term survival analysis.
    Onder S; Fayda M; Karanlık H; Bayram A; Şen F; Cabioglu N; Tuzlalı S; İlhan R; Yavuz E
    Breast J; 2017 Nov; 23(6):638-646. PubMed ID: 28543794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinico-pathological features and prognosis of invasive micropapillary carcinoma compared to invasive ductal carcinoma: a population-based study from China.
    Shi WB; Yang LJ; Hu X; Zhou J; Zhang Q; Shao ZM
    PLoS One; 2014; 9(6):e101390. PubMed ID: 24977705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.